Neural Mechanisms Associated With Risk of Smoking Relapse
Sponsor: National Institute on Drug Abuse (NIDA)
Listed as NCT02837510, this NA trial focuses on Nicotine Addiction and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 16 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
16 versions recorded-
Apr 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Apr 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Oct 2023 — Jan 2024 [monthly]
Active Not Recruiting NA
▶ Show 11 earlier versions
-
Aug 2023 — Oct 2023 [monthly]
Active Not Recruiting NA
-
Jun 2023 — Aug 2023 [monthly]
Active Not Recruiting NA
-
Mar 2023 — Jun 2023 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Mar 2023 [monthly]
Active Not Recruiting NA
-
May 2021 — Sep 2022 [monthly]
Active Not Recruiting NA
-
Feb 2021 — May 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Jan 2020 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2019 — Jan 2020 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Drug Abuse (NIDA)
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .